Europe Negative Pressure Wound Therapy Market Forecast by 2033
Market Size in 2024: USD 600.0 Million
Market Forecast in 2033: USD 780.7 Million
Market Growth Rate 2025-2033: 2.82%
The Europe negative pressure wound therapy market is expanding steadily. Valued at USD 600 million in 2024, the market is projected to reach USD 780.7 million by 2033, growing at a CAGR of 2.82%. This moderate yet consistent growth is driven by rising rates of diabetes and obesity, an ageing population, and increasing adoption of minimally-invasive wound-care solutions.
Europe Negative Pressure Wound Therapy Market Growth Drivers
Rising Diabetes & Obesity Burden Across the EU
Eurostat data from 2024 shows there are now 32.5 million adults in the EU who have diabetes. This number is up 8% from 2020. Diabetic foot ulcers are very common. They make up about 15% of all hospital bed days in Germany. Because of this, national diabetic care programs now ask for faster NPWT referral steps. In France, HAS (Haute Autorité de Santéchanged its clinical advice in January 2025. Now, they say NPWT should be used for all Wagner Grade 2 and higher ulcers within 14 days after they are found. These new rules are speeding up how people get these devices in hospitals and homes.
Ageing Demographics & Home-Care Incentives
The European Commission says that by 2030, one out of every five people in Europe will be over 65. As people get older, their skin ages. This can make wounds heal more slowly, and there is a bigger chance that they will have chronic wounds. Because of costs linked to infections caught in hospitals, NHS England started a Home NPWT Framework in April 2025. It is worth £45 million. It pays for battery-operated, single-use devices for patients who meet the rules. Tests finished in March 2025 showed that there was a 22% drop in the number of people going back to the hospital. There was also an average cost saving of £1,270 for each patient. This led to more money being given for portable NPWT systems.
Technological Leap to Lightweight, Battery-Operated Devices
Old NPWT pumps used to weigh more than 3 kg and kept people connected to a wall plug. Now, new devices are getting rid of these problems. In February 2025, a group led by Charité Hospital Berlin tested a single-use NPWT device that weighs only 400 grams. This system can be controlled with a smartphone, runs at â125 mmHg, and lasts 7 days on just one charge. The device has the CE mark and, in May 2025, got quick approval for payment from Germany’s G-BA. These new products are helping more people use therapy at outpatient surgery centres and while on the go. This has helped boost device sales all over Europe.
Request your complimentary sample of the full report here: https://www.imarcgroup.com/Europe-Negative-Pressure-Wound-Therapy-Market/requestsample
Europe Negative Pressure Wound Therapy Market Segmentation:
Breakup by Device
Conventional NPWT Devices
Single-Use NPWT Devices
Accessories
Breakup by Component
Canisters and Dressings
Pumps
Breakup by Wound Type
Chronic Wounds
Acute Wounds
Breakup by Indication
Surgical and Traumatic Wounds
Pressure Ulcers
Venous Ulcers
Diabetic Foot Ulcer
Burns
Others
Breakup by End User
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings
Others
Breakup by Country
Germany
France
United Kingdom
Italy
Spain
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Europe Negative Pressure Wound Therapy Market News:
May 2025: A pan-European clinical trial led by Charité Berlin demonstrates that a new 400-g smartphone-controlled single-use NPWT device cuts healing time by 18 % versus conventional pumps.
April 2025: NHS England expands its Home NPWT Framework to cover all adult diabetic foot ulcers, backed by £45 million in new funding.
January 2025: France’s HAS updates diabetic-foot guidelines, recommending NPWT initiation within 14 days for Wagner Grade 2+ ulcers.
February 2024: European Wound Management Association launches an online NPWT training module for community nurses, aiming to standardise therapy delivery across member states.
Key highlights of the Report:
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.